📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Pharmacologically Active Alkaloid Cryptolepine Activates a Type 1 Interferon Response That Is Independent of MAVS and STING Pathways. (2022)

First Author: Domfeh SA

Attributed to: Viral manipulation of DBC1: a novel strategy to promote cell survival and suppress inflammation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1155/2022/8873536

PubMed Identifier: 35928633

Publication URI: http://europepmc.org/abstract/MED/35928633

Type: Journal Article/Review

Volume: 2022

Parent Publication: Journal of immunology research

ISSN: 2314-7156